This paper described the outcomes of 119 patients who achieved CR after induction therapy, including 54 PTCL‐NOS, 35 AITL, and 30 ALK‐negative ALCL. The gene discussed is ALK; the disease is angioimmunoblastic T-cell lymphoma.